High‐Performance Prevascularized SHED‐Laden rGO@Hydrogel Achieves Optimized Diabetic Bone Defect Repair
Source abstract
Abstract
ABSTRACT Diabetic bone defects repair is severely hindered by impaired angiogenesis and delayed osteogenesis. Conventional tissue‐engineered scaffolds often fail to achieve effective vascularization due to the compromised angiogenic capacity of host endothelial cells in the hyperglycemic microenvironment. Here, we developed a prevascularized scaffold by encapsulating stem cells from human exfoliated deciduous teeth (SHED), which shared developmental origin to craniofacial bone, within a reduced graphene oxide (rGO)‐integrated hydrogel. rGO significantly accelerated SHED‐mediated formation of vascular networks in vitro. The scaffold's therapeutic efficacy was confirmed in a clinically relevant diabetic beagle dog mandibular defect model, which showed increased vascular density and accelerated bone regeneration. Mechanistic validation revealed that rGO activates the FAK‐Src/RELA pathway to upregulate P4HA1, subsequently enhancing collagen I synthesis and driving extracellular matrix (ECM) remodeling to create a pro‐angiogenic niche. This study demonstrates that engineering the ECM with rGO is a novel strategy to accelerate prevascularization and bone repair in diabetic conditions.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Bone Tissue Engineering Materials · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Stomatological Hospital Southern Medical University Guangzhou China
Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering Guangzhou China
Funding
National Natural Science Foundation of China
References (69)
Show source-provided references
1. 10.1038/s41467‐025‐65165‐510.1038/s41467‐025‐65165‐5 ↗
2. 10.1186/s12951‐025‐03358‐210.1186/s12951‐025‐03358‐2 ↗
3. Strategies for Craniofacial Tissue Engineering: Innovations for Scalable Bone Regeneration
4. 10.1021/acsnano.4c1522710.1021/acsnano.4c15227 ↗
5. 10.1002/adma.20250506110.1002/adma.202505061 ↗
6. 10.1002/advs.20250643810.1002/advs.202506438 ↗
7. 10.1016/j.biomaterials.2025.12333410.1016/j.biomaterials.2025.123334 ↗
8. 10.1016/j.bmt.2023.06.00210.1016/j.bmt.2023.06.002 ↗
9. 10.1016/j.compositesb.2023.11064210.1016/j.compositesb.2023.110642 ↗
10. 10.1002/adma.20241096210.1002/adma.202410962 ↗
11. 10.1002/advs.20241545910.1002/advs.202415459 ↗
12. 10.1016/j.bioactmat.2024.06.02110.1016/j.bioactmat.2024.06.021 ↗
13. 10.1002/adhm.20250137610.1002/adhm.202501376 ↗
14. 10.1021/acsami.4c0506210.1021/acsami.4c05062 ↗
15. 10.1016/j.bmt.2025.10009910.1016/j.bmt.2025.100099 ↗
16. 10.1089/ten.teb.2021.000410.1089/ten.teb.2021.0004 ↗
17. 10.1016/j.biomaterials.2022.12145110.1016/j.biomaterials.2022.121451 ↗
18. 10.1177/0022034524127112210.1177/00220345241271122 ↗
19. 10.1002/sctm.19‐039810.1002/sctm.19‐0398 ↗
20. 10.1016/j.actbio.2017.07.01710.1016/j.actbio.2017.07.017 ↗
21. 10.1038/s41419‐021‐03925‐z10.1038/s41419‐021‐03925‐z ↗
22. 10.1111/iej.1409910.1111/iej.14099 ↗
23. 10.1016/j.bioactmat.2022.01.02110.1016/j.bioactmat.2022.01.021 ↗
24. 10.1021/acsnano.4c0697910.1021/acsnano.4c06979 ↗
25. 10.1021/acsnano.9b0807810.1021/acsnano.9b08078 ↗
26. 10.20517/2347‐9264.2024.15310.20517/2347‐9264.2024.153 ↗
27. 10.1016/j.rechem.2023.10127010.1016/j.rechem.2023.101270 ↗
28. 10.1016/j.ijbiomac.2024.13252110.1016/j.ijbiomac.2024.132521 ↗
29. 10.3390/ijms24151229310.3390/ijms241512293 ↗
30. 10.1016/j.jshs.2016.05.00510.1016/j.jshs.2016.05.005 ↗
31. 10.3390/antiox1105091910.3390/antiox11050919 ↗
32. 10.3390/nu1417360210.3390/nu14173602 ↗
33. 10.1002/advs.20220529210.1002/advs.202205292 ↗
34. 10.1039/C7NR02943H10.1039/C7NR02943H ↗
35. 10.1002/advs.20251151310.1002/advs.202511513 ↗
36. 10.1186/s12951‐025‐03816‐x10.1186/s12951‐025‐03816‐x ↗
37. 10.1088/2516‐1091/abc94710.1088/2516‐1091/abc947 ↗
38. 10.1038/s41580‐022‐00508‐410.1038/s41580‐022‐00508‐4 ↗
39. 10.1126/sciadv.ade166010.1126/sciadv.ade1660 ↗
40. 10.1038/s41592‐024‐02277‐810.1038/s41592‐024‐02277‐8 ↗
41. 10.1111/febs.1577610.1111/febs.15776 ↗
42. 10.1016/j.addr.2017.07.01410.1016/j.addr.2017.07.014 ↗
43. 10.1007/s40820‐024‐01557‐410.1007/s40820‐024‐01557‐4 ↗
44. 10.1016/j.biomaterials.2012.10.02710.1016/j.biomaterials.2012.10.027 ↗
45. 10.1016/j.jpor.2014.08.00310.1016/j.jpor.2014.08.003 ↗
46. 10.1016/j.tibs.2004.11.00910.1016/j.tibs.2004.11.009 ↗
47. 10.1038/s41392‐021‐00652‐x10.1038/s41392‐021‐00652‐x ↗
48. 10.1074/jbc.M111.28421610.1074/jbc.M111.284216 ↗
49. 10.1016/j.canlet.2008.03.04510.1016/j.canlet.2008.03.045 ↗
50. 10.1161/CIRCULATIONAHA.119.04067610.1161/CIRCULATIONAHA.119.040676 ↗
51. 10.1016/j.addr.2021.05.03010.1016/j.addr.2021.05.030 ↗
52. 10.1074/jbc.M60807420010.1074/jbc.M608074200 ↗
53. 10.12659/msm.88192710.12659/msm.881927 ↗
54. 10.1039/C9FO01346F10.1039/C9FO01346F ↗
55. 10.1016/j.bone.2010.03.01410.1016/j.bone.2010.03.014 ↗
56. 10.4049/jimmunol.173.1.50710.4049/jimmunol.173.1.507 ↗
57. 10.1038/s41419‐019‐1947‐910.1038/s41419‐019‐1947‐9 ↗
58. 10.1039/C9NR09577B10.1039/C9NR09577B ↗
59. 10.1093/cvr/cvaf24610.1093/cvr/cvaf246 ↗
60. 10.1039/C4TB00976B10.1039/C4TB00976B ↗
61. 10.1016/j.tibtech.2016.12.00110.1016/j.tibtech.2016.12.001 ↗
62. 10.1039/C9FD00094A10.1039/C9FD00094A ↗
63. 10.1073/pnas.093763510010.1073/pnas.0937635100 ↗
64. 10.1002/advs.20231028510.1002/advs.202310285 ↗
65. 10.1016/j.bioactmat.2022.03.02110.1016/j.bioactmat.2022.03.021 ↗
66. 10.1016/j.bioactmat.2022.09.00710.1016/j.bioactmat.2022.09.007 ↗
67. 10.1016/j.jare.2025.05.02310.1016/j.jare.2025.05.023 ↗
68. 10.1186/1471‐2172‐11‐4410.1186/1471‐2172‐11‐44 ↗
69. 10.1167/iovs.61.6.4510.1167/iovs.61.6.45 ↗